V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20039106 | 20133400 | 1.61 | 104 | null | null | 2018-11-14 | null | null | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101612588 |
| 20039175 | 20133401 | 1.6 | 69 | Palliative (P) | 2022-04-04 | 2022-04-18 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100058274 |
| 20039200 | 20133402 | 1.68 | 62.8 | null | 2020-01-27 | 2020-02-12 | null | 02 | null | PEMBROLIZUMAB | 100859091 |
| 20039320 | 20133404 | 1.75 | 66.3 | Adjuvant (A) | 2018-11-16 | 2019-12-18 | null | 02 | N | PEMBROLIZUMAB | 101592294 |
| 20039339 | 20133405 | 1.62 | 87.9 | null | 2017-09-04 | 2017-09-04 | null | N | null | ENZALUTAMIDE | 100562505 |
| 20039423 | 20133406 | 1.72 | 64.5 | Disease modification (D) | 2017-07-01 | 2017-07-04 | null | 02 | N | CETUXIMAB + ENCORAFENIB | 100458458 |
| 20039454 | 20133407 | 1.82 | 84.6 | Palliative (P) | 2019-04-07 | 2019-04-08 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100045295 |
| 20039561 | 20133409 | 1.55 | 67 | Curative (C) | 2019-07-21 | 2019-08-15 | null | 02 | N | PEMBROLIZUMAB | 101410267 |
| 20039587 | 20133410 | 1.56 | 71.2 | Neo-adjuvant (N) | 2019-02-26 | 2019-03-07 | null | 02 | N | CAPECITABINE + CISPLATIN + RT | 100986082 |
| 20039610 | 20133411 | 1.63 | 0 | Palliative (P) | 2017-09-24 | 2017-09-30 | null | 02 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100180644 |
| 20039613 | 20133412 | 0 | 0 | Palliative (P) | 2018-08-01 | 2018-08-14 | null | N | N | PEMBROLIZUMAB | 101844247 |
| 20039631 | 20133413 | null | 67.35 | null | 2018-09-15 | 2018-09-17 | null | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101592259 |
| 20039664 | 20133414 | 1.82 | 56.2 | Curative (C) | 2018-04-01 | 2018-05-24 | EVEROLIMUS | 02 | Y | EVEROLIMUS | 100217147 |
| 20039667 | 20133415 | 1.6 | 60.5 | Palliative (P) | 2018-02-16 | 2018-02-16 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100651558 |
| 20039805 | 20133416 | 1.85 | 84.2 | Neo-adjuvant (N) | 2018-04-08 | 2018-04-08 | null | 02 | null | SCALOP-2 TRIAL | 100410436 |
| 20039900 | 20133417 | 1.52 | 62.4 | Curative (C) | null | 2018-08-01 | null | 02 | Y | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101339465 |
| 20039973 | 20133419 | 1.85 | null | Palliative (P) | 2016-10-18 | 2016-12-02 | LUTETIUM-177 | N | N | NOT MATCHED | 100164103 |
| 20039977 | 20133420 | 1.66 | 3.3 | Palliative (P) | null | 2016-12-03 | null | N | N | ATEZOLIZUMAB + BEVACIZUMAB | 100786871 |
| 20039986 | 20133421 | 1.6 | 71 | null | null | 2019-11-24 | null | N | null | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100683547 |
| 20040110 | 20133422 | 1.75 | null | null | 2019-02-18 | 2019-02-18 | null | 02 | null | OXALIPLATIN | 101345683 |
| 20040165 | 20133423 | 0 | 86.6 | null | null | 2018-01-13 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100210046 |
| 20040390 | 20133426 | 1.59 | 75.2 | null | 2017-10-12 | 2017-11-17 | null | 02 | null | NOT MATCHED | 100153012 |
| 20040441 | 20133427 | 1.6 | 56.6 | Palliative (P) | 2017-11-15 | 2017-11-17 | null | 02 | N | SUNITINIB | 100976006 |
| 20040564 | 20133429 | 1.66 | 79.3 | null | 2018-03-18 | 2018-03-19 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 100304875 |
| 20040598 | 20133430 | null | 53.7 | Palliative (P) | 2019-08-09 | 2019-08-15 | null | N | N | SUNITINIB | 100416866 |
| 20040608 | 20133431 | 1.65 | 72.1 | Curative (C) | 2015-03-30 | 2017-02-14 | null | 2 | N | OCTREOTIDE | 101336625 |
| 20040659 | 20133432 | 1.75 | 0 | null | 2018-02-21 | 2018-03-09 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 101027326 |
| 20040675 | 20133433 | null | 61 | null | 2015-05-27 | 2015-06-19 | null | 02 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 101180233 |
| 20040760 | 20133434 | 1.57 | 99.3 | Curative (C) | null | 2016-11-21 | null | 99 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100248847 |
| 20040763 | 20133435 | 1.6 | null | null | 2016-08-09 | 2016-08-10 | null | 02 | null | ABIRATERONE | 101543411 |
| 20040938 | 20133437 | null | null | Palliative (P) | 2019-05-30 | 2019-06-21 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100966600 |
| 20040998 | 20133438 | 1.55 | 58 | Palliative (P) | 2016-05-24 | 2016-05-28 | null | N | N | SUNITINIB | 101468702 |
| 20041002 | 20133439 | 1.55 | 87.9 | Palliative (P) | 2018-06-01 | 2018-10-07 | EVEROLIMUS | 02 | N | EVEROLIMUS | 100600973 |
| 20041049 | 20133440 | 1.76 | 83.6 | null | 2015-04-06 | 2017-04-29 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100350537 |
| 20041066 | 20133441 | 1.74 | 57 | Palliative (P) | 2018-07-12 | 2018-08-08 | null | 02 | N | CISPLATIN | 101154721 |
| 20041159 | 20133443 | 1.65 | 67 | 03 | 2017-02-19 | 2017-02-20 | null | 02 | N | PEMBROLIZUMAB | 100063921 |
| 20041188 | 20133444 | 1.8 | 66.4 | null | 2019-12-03 | 2019-12-10 | null | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101539650 |
| 20041220 | 20133445 | 0 | 91 | Curative (C) | 2022-01-01 | 2022-01-02 | EVEROLIMUS | 02 | Y | EVEROLIMUS | 100365462 |
| 20041273 | 20133446 | null | 50.9 | null | 2018-10-09 | 2018-10-31 | null | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101214194 |
| 20041369 | 20133447 | 1.67 | 0 | Curative (C) | 2016-10-06 | 2016-10-07 | null | 02 | Y | LUTETIUM-177 | 100858576 |
| 20041408 | 20133449 | 1.85 | null | Curative (C) | 2015-06-13 | 2015-06-14 | null | N | Y | PEMBROLIZUMAB | 100302980 |
| 20041465 | 20133450 | 1.61 | 64.4 | Palliative (P) | 2017-10-08 | 2017-10-17 | null | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101035874 |
| 20041503 | 20133451 | 1.6 | 71.8 | Curative (C) | 2018-08-17 | 2018-08-18 | null | 02 | N | SUNITINIB | 100726145 |
| 20041510 | 20133452 | 1.68 | 83.6 | null | 2019-01-29 | 2019-01-29 | null | 02 | null | CISPLATIN + ETOPOSIDE | 101416304 |
| 20041515 | 20133453 | 1.88 | 56.2 | null | 2019-09-01 | 2019-09-20 | null | 2 | null | ATEZOLIZUMAB + BEVACIZUMAB | 101680811 |
| 20041527 | 20133454 | 1.57 | null | null | 2020-11-21 | 2021-01-07 | null | 02 | null | LENALIDOMIDE | 101475327 |
| 20041565 | 20133455 | null | null | null | 2017-05-05 | 2017-05-17 | Capecitabine + Cisplatin + RT | 02 | null | SUNITINIB | 101350071 |
| 20041686 | 20133456 | 1.71 | 66.4 | Palliative (P) | null | 2018-04-24 | null | N | null | ENZALUTAMIDE | 100979582 |
| 20041781 | 20133457 | 1.8 | 0 | null | 2016-09-25 | 2016-10-13 | null | 02 | null | SCALOP-2 TRIAL | 100417694 |
| 20041883 | 20133459 | 1.82 | 77 | Neo-adjuvant (N) | 2017-10-28 | 2018-03-09 | null | 02 | null | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100552074 |